Kaposi's Sarcoma & HIV/AIDS: Research
- Chemotherapy Plus ART Best Treatment for Kaposi's Sarcoma in South African Study (February 20, 2010)
From aidsmap.com
- UCSF Researchers Identify New Drug Target for Kaposi's Sarcoma (July 29, 2009)
Researchers believe that engineering a new type of protease inhibitor could prove to be an effective form of KS treatment.
From University of California-San Francisco
- Early KS Can Be Successfully Treated With HIV Treatment and No Need for Chemotherapy (April 7, 2009)
From aidsmap.com
- Peculiar Type of KS Emerges in Healthier Individuals (November 7, 2008)
From Project Inform
- New Type of Kaposi’s Sarcoma Seen in HIV-Negative Gay Men (June 18, 2008)
From aidsmap.com
- Scoring Tool Predicts Risk of KS Progression (June 12, 2008)
- Physicians in S.F. Identify Kaposi's Sarcoma Cluster Among HIV-Infected MSM (October 15, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Incidence of AIDS-Associated and Non-AIDS-Associated Malignancies Among HIV-Infected Individuals (February 6, 2006)
Recent studies examine the risks for Kaposi's sarcoma, non-Hodgkin's lymphoma, cervical cancer, lung cancer and other malignancies.
In The 13th Conference on Retroviruses and Opportunistic Infections
- Human Herpesvirus-8, Kaposi Sarcoma, and AIDS-Associated Neoplasms (January 2006)
A clinical overview from the comprehensive, online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite
- HAART May Need Help to Treat Severe Kaposi's Sarcoma, Study Suggests (August 20, 2004)
For those with moderate to severe KS, chemotherapy plus HAART is found to work better than HAART alone, in contradiction to earlier studies.
From aidsmap.com
- New Discovery on Kaposi's Sarcoma May Yield Better Testing, Treatment (June 28, 2004)
British scientists say they have finally discovered the location within the human immune system where Kaposi's sarcoma first develops.
From Agence de Presse Medicale
- Kaposi's Sarcoma Incidence Down 90% Since 1994, Study Finds (May 12, 2004)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- HIV-Positive Men With HHV-8 Coinfection Face Increased Risk of Developing Kaposi's Sarcoma, Study Says (August 22, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- French Doctors Suggest That Therapy Switch May Cause KS Relapse (July 8, 2003)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Kaposi's Sarcoma: An Update (Spring 2003)
[Archived Article]
In ACRIA Update, from AIDS Community Research Initiative of America
- Low-Dose Etoposide Effective Against High-Risk Kaposi's Sarcoma (November 20, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Monkey Virus May Provide Clues to Kaposi's Virus (October 11, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Ritonavir Can Reduce Kaposi's Sarcoma Risk (July 18, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- AIDS-Related Cancer Triggered by Cut: Report (April 26, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Relationship Between Kaposi Sarcoma-Associated Herpesvirus and HIV (March 27, 2002)
[Archived Article]
In Journal of the American Medical Association
- Efavirenz Helps Get Rid of Kaposi's Sarcoma (February 14, 2002)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Can Low-Dose Shark Cartilage Shrink Kaposi's Sarcoma (KS)? (September 25, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- Effect of HAART on Survival with Kaposi's Sarcoma and Non-Hodgkin's Lymphoma (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- 4th International AIDS Malignancy Conference (May 16-18, 2000)
In The 4th International AIDS Malignancy Conference, from The Body PRO
- Efficacy and Safety of Long-Term Alitretinoin Gel (Panretin®) for Cutaneous AIDS-Related Kaposi's Sarcoma (May 16-18, 2000)
[Archived Article]
In The 4th International AIDS Malignancy Conference, from The Body PRO
- Transmission of Human Herpes Virus Type 8 (HHV-8, The Kaposi's Sarcoma-Associated Herpes Virus) (May 16-18, 2000)
[Archived Article]
In The 4th International AIDS Malignancy Conference, from The Body PRO
- Risk of HIV Related Kaposi's Sarcoma and Non-Hodgkin's Lymphoma with Potent Antiretroviral Therapy: Prospective Cohort Study (July 3, 1999)
[Archived Article]
In British Medical Journal
- HIV-Related Neoplasia: Advances and Controversies (February 1999)
[Archived Article]
Coverage of the 6th Retroviruses Conference.
From Seattle Treatment Education Project
- What's New in Kaposi's Sarcoma Research (Winter 1998)
[Archived Article]
In STEP Perspective, from Seattle Treatment Education Project
- HIV-Related Clinical Updates: Oncologic Disorders and Cytokines (May 2, 1998)
[Archived Article]
In The 8th Clinical Care Options for HIV Symposium, from The Body PRO
- KSHV Study in HIV-Negative Individuals (February 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Kaposi's Sarcoma: Report From the Third International Conference on Drug Therapy in HIV Infection (November 1996)
[Archived Article]
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
- Kaposi's Sarcoma: Doxil Versus Bleomycin + Vincristine (September 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Studies Strengthen Link Between HHV-8 Virus and KS (September 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Profiles on New Drugs (March 1996)
[Archived Article]
In Moore News for Care Providers, from Johns Hopkins AIDS Service
- New Anti-HIV Vaccine and KS Trials at the National Cancer Institute (February 1996)
[Archived Article]
By Robert Yarchoan, M.D., Chief, Retroviral Diseases Section, MB, DCS.
From National Cancer Institute
- KS Report From Yokohama (November 1994)
[Archived Article]
In TAGline, from Treatment Action Group
- The KS Project Report (October 1994)
[Archived Article]
In TAGline, from Treatment Action Group
- KS Proves Formidable Foe (May 1994)
[Archived Article]
In TAGline, from Treatment Action Group
|
Advertisement
|
Email
Glossary
